Skip to content
Governance Register

← US public companies

Shanafelt Armen

SEC-identified person · CIK 1656151 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Surface Oncology, Inc. SURF Director filed 2018–2022
Spyre Therapeutics, Inc. SYRE Director filed 2016–2022
Rein Therapeutics, Inc. RNTX Director filed 2017–2018
Protagonist Therapeutics, Inc PTGX Director filed 2016–2018

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.